MOGAM
Green Cross Holdings Corporation
Application Filed: 2016-07-28
Trademark Application Details
FOURTH EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87119985 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Yoon S. Ham |
| Attorney Docket Number | 5734-0075TM |
| Law Office Assigned | L10 |
| Employee Name | GOODSAID, IRA J |
Timeline
| 2016-07-28 | Application Filed |
| 2017-07-11 | Published for Opposition |
| 2017-09-05 | Location: INTENT TO USE SECTION |
| 2019-08-12 | Status: Live/Pending |
| 2019-08-14 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Green Cross Holdings Corporation |
| Address | 107, Ihyeon-ro 30beon-gil, Giheung-gu Yongin-si, Gyeongg KR |
| Legal Entity Type | Corporation |
| Legal Entity State | KR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, hepatitis, HIV, Hunter syndrome, hemophilia, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, clostridium tetani, influenza, chronic pain and kidney diseases; pharmaceutical preparations for use in ocular or intraocular surgery, chemotherapy, dermatology and urology; blood plasma derivatives for medical purposes; vaccines; enzyme preparations for medical purposes; protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing and treatment of hepatitis B and influenza |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-08-01 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-08-02 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2016-11-08 | 3 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2016-11-08 | 4 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2016-11-08 | 5 GPRA F:First Action |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2016-11-08 | 6 GPRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-04-04 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2017-04-16 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-04-28 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-04-28 | 10 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2017-04-29 | 11 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2017-04-29 | 12 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2017-04-29 | 13 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2017-05-26 | 14 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-06-02 | 15 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-06-02 | 16 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-06-02 | 17 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2017-06-06 | 18 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-06-21 | 19 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-07-11 | 20 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-07-11 | 21 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-09-05 | 22 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-01-30 | 23 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2018-01-30 | 24 EXT1 S: |
| EXTENSION 1 GRANTED | 2018-01-30 | 25 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-02-01 | 26 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-09-04 | 27 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2018-09-04 | 28 EXT2 S: |
| EXTENSION 2 GRANTED | 2018-09-04 | 29 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-09-06 | 30 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-02-12 | 31 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2019-02-12 | 32 EXT3 S: |
| EXTENSION 3 GRANTED | 2019-02-12 | 33 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-02-14 | 34 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-08-12 | 35 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2019-08-12 | 36 EXT4 S: |
| EXTENSION 4 GRANTED | 2019-08-12 | 37 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-08-14 | 38 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-03-03 | 39 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-03-11 | 40 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2020-03-03 | 41 EXT5 S: |
| EXTENSION 5 GRANTED | 2020-03-12 | 42 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-03-13 | 43 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2020-10-12 | 44 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2020-10-13 | 45 MAB6 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 